Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-23-206895
Filing Date
2023-08-09
Accepted
2023-08-09 09:32:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM d513885dposam.htm POS AM 18883
  Complete submission text file 0001193125-23-206895.txt   20104
Mailing Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-566-1402
DICE Therapeutics, Inc. (Filer) CIK: 0001645569 (see all company filings)

EIN.: 472286244 | State of Incorp.: DE | Fiscal Year End: 1230
Type: POS AM | Act: 33 | File No.: 333-267702 | Film No.: 231153650
SIC: 2834 Pharmaceutical Preparations